We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
INTEGRA BIOSCIENCES AG

Download Mobile App




Carcinogenic Effect of Asbestos Linked to Chronic Inflammation

By LabMedica International staff writers
Posted on 15 Jul 2010
Cancer researchers have identified the molecular basis for how a potent cytotoxic agent like asbestos is able to function as a carcinogen.

Exposure to asbestos is associated with the risk of developing mesothelioma, a malignant cancer of the membranes that cover the lungs and abdomen and is resistant to current therapies. More...
Since asbestos kills human mesothelial cells (HM), it has been difficult to understand how this substance could also act to trigger mesothelioma formation.

Now, a study published in June 28, 2010, online edition of the journal Proceedings of the [U.S.] National Academy of Sciences (PNAS) has presented an explanation for this paradox by linking asbestos-induced HM cell death, which is a regulated form of necrosis, to carcinogenesis.

Asbestos-exposed HM cells activate the enzyme poly(ADP-ribose) polymerase, secrete hydrogen peroxide, deplete ATP, and translocate high-mobility group box 1 protein (HMGB1) from the nucleus to the cytoplasm, and into the extracellular space. The release of HMGB1 induces macrophages to secrete TNF-alpha (tumor necrosis factor-alpha), which protects HM from asbestos-induced cell death and triggers a chronic inflammatory response. Protection from cell death in an environment of chronic inflammation favors transformation of HM into cancer cells.

This study emphasized the role of inflammation in the development of mestothelioma and suggested novel clinical tools to identify exposed individuals and prevent or decrease tumor growth. The investigators at the Cancer Research Center of Hawaii (Honolulu, USA) ponder whether it is possible to prevent mesothelioma, like colon cancer, simply by taking aspirin or similar drugs that stop inflammation. This hypothesis will be tested in future studies.

Related Links:

Cancer Research Center of Hawaii




Platinum Member
COVID-19 Rapid Test
OSOM COVID-19 Antigen Rapid Test
Verification Panels for Assay Development & QC
Seroconversion Panels
Complement 3 (C3) Test
GPP-100 C3 Kit
Gold Member
Real-Time PCR System
Gentier 96T
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Clinical Chemistry

view channel
Image: QIP-MS could predict and detect myeloma relapse earlier compared to currently used techniques (Photo courtesy of Adobe Stock)

Mass Spectrometry-Based Monitoring Technique to Predict and Identify Early Myeloma Relapse

Myeloma, a type of cancer that affects the bone marrow, is currently incurable, though many patients can live for over 10 years after diagnosis. However, around 1 in 5 individuals with myeloma have a high-risk... Read more

Immunology

view channel
Image: The cancer stem cell test can accurately choose more effective treatments (Photo courtesy of University of Cincinnati)

Stem Cell Test Predicts Treatment Outcome for Patients with Platinum-Resistant Ovarian Cancer

Epithelial ovarian cancer frequently responds to chemotherapy initially, but eventually, the tumor develops resistance to the therapy, leading to regrowth. This resistance is partially due to the activation... Read more

Technology

view channel
Image: Ziyang Wang and Shengxi Huang have developed a tool that enables precise insights into viral proteins and brain disease markers (Photo courtesy of Jeff Fitlow/Rice University)

Light Signature Algorithm to Enable Faster and More Precise Medical Diagnoses

Every material or molecule interacts with light in a unique way, creating a distinct pattern, much like a fingerprint. Optical spectroscopy, which involves shining a laser on a material and observing how... Read more

Industry

view channel
Image: The collaboration aims to leverage Oxford Nanopore\'s sequencing platform and Cepheid\'s GeneXpert system to advance the field of sequencing for infectious diseases (Photo courtesy of Cepheid)

Cepheid and Oxford Nanopore Technologies Partner on Advancing Automated Sequencing-Based Solutions

Cepheid (Sunnyvale, CA, USA), a leading molecular diagnostics company, and Oxford Nanopore Technologies (Oxford, UK), the company behind a new generation of sequencing-based molecular analysis technologies,... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.